The role of GLP-1 receptor agonists in cardiovascular disease
Rapid physiological changes, combined with the psychological adjustment of dramatically altered eating patterns, can trigger anxiety in susceptible individuals
In the 30-49 age group, 3% had used GLP-1s to treat chronic conditions, 6% for weight loss, and 2% for both
Record the dosage of injection, time, date, and injection site in your journal or tracking app to show it to your healthcare professional
This is more manageable than targeting based on total weight
Retatrutide is a triple-receptor agonist that targets GIP, GLP-1, and glucagon receptors, making it a particularly powerful option for weight management and metabolic health